Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03347565 · ClinicalTrials.gov registry record
Brain Function in Adolescent Eating Disorders and Healthy Peers
A clinical trial of Eating Disorder, sponsored by University of California, San Diego.
- Active
- Registry status
- 155
- Enrollment target
- 1
- Study location
NCT03347565: Active study of Eating Disorder, sponsored by University of California, San Diego.
NCT03347565 is a study of Eating Disorder that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 155 participants, above the 103-participant average among 9 other Eating Disorder trials with a reported enrollment target (50% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03347565, a study of Eating Disorder, is active but no longer recruiting, sponsored by University of California, San Diego.
- ACTIVE NOT RECRUITING
- Registry status
- 155 participants
- Enrollment target
- 1
- Study location
Study Summary
This study of adolescent eating disorders (ED) will examine the association of temperament-based classifications, brain activation during incentive processing, and ED symptoms at time of scan and 1 year later to better understand the neurobiology and symptoms of ED. We will recruit 150 females currently ill with an ED and 50 controls ages 14-17 to investigate how temperaments reflecting greater inhibition, impulsivity, or effortful control correspond to 1) clinical symptoms and 2) the brain's response to anticipation and outcome of salient stimuli, and 3) by collecting follow-up clinical data one year later, identify how temperament-based subtypes predict ED symptom change (e.g., clinical prediction). Data collection will rely on a technology called functional magnetic resonance imaging (fMRI).
Primary Outcome
Functional Magnetic Resonance imaging will be used to assess brain activation associated with inhibition, impulsivity, and control
Conditions Studied
Study Locations (1)
California
- University of California San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2017-07-21 |
| Est. Completion | 2025-11 |
What the registry record for NCT03347565 still lists
NCT03347565 is an observational study that tracks outcomes without assigning an intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, above the 103-participant average among 9 other Eating Disorder trials with a reported enrollment target (50% higher).
The record links to 1 condition, with Eating Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT03347565 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03347565 about?
NCT03347565 is a clinical study titled "Brain Function in Adolescent Eating Disorders and Healthy Peers". This study of adolescent eating disorders (ED) will examine the association of temperament-based classifications, brain activation during incentive processing, and ED symptoms at time of scan and 1 year later to better understand the neurobiology and symptoms of ED. We will recruit 150 females curre...
What is the current status of trial NCT03347565?
This trial is currently active not recruiting. The enrollment target is 155 participants. The study started on 2017-07-21. Estimated completion is 2025-11.
What conditions does trial NCT03347565 study?
This clinical trial studies the following conditions: Eating Disorder.
Who is sponsoring clinical trial NCT03347565?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03347565 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eating Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03347565's enrollment target sits among peer trials
155 2nd of 9 the highest of 9 other Eating Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eating Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Development and Testing of a Peer-Coaching Model for the Treatment of Eating Disorders
RECRUITING · NA
-
Effects of Negative Affect in Individuals With Binge Eating Episodes
ACTIVE NOT RECRUITING · NA
-
Uniting Couples In the Treatment of Eating Disorders (UNITE)
COMPLETED · NA
-
The Effects of Yoga on Body Image in College Women
COMPLETED · NA
-
Characteristics of Persons With an Eating Disorder and Type 1 Diabetes
COMPLETED
-
A Pilot Test of Mood and Circadian Rhythm Mechanisms Driving Binge Eating
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI